Search Results for "Is Metformin Hydrochloride The Same As Metformin"

11:14 EST 24th November 2014 | BioPortfolio

Original Source: METFORMIN HYDROCHLORIDE [State of Florida DOH Central Pharmacy]

METFORMIN HYDROCHLORIDE

Matching Channels

None

Matching News

FDA Accepts NDA for Empagliflozin/Metformin Fixed-Dose Combination

The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investig...

FDA Approves Xigduo XR (dapagliflozin and metformin hydrochloride) for Type 2 Diabetes

WILMINGTON, Del., October 30, 2014 -- AstraZeneca today announced that the U.S. Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-relea...

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin / metformin, Revision: 10, Authorised

FDA OKs Xigduo XR, a New Dapagliflozin-Metformin Combo

Xigduo XR is the first diabetes drug in the United States to combine a sodium glucose cotransporter-2 inhibitor with metformin hydrochloride extended-release. FDA Approvals

FDA Approves Invokamet (canagliflozin/metformin) for Type 2 Diabetes

RARITAN, N.J., August 8, 2014 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved Invokamet, a fixed dose therapy combining canagliflozin and met...

Type 2 diabetes: Jentadueto® (linagliptin and metformin hydrochloride) tablets label updated to include new data on blood glucose reductions in treatment-naive adults with high baseline A1C

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 4, 2014 /PRNewswire/ --  The U.S. Prescribing Information for Jentadueto® (linagliptin and metformin hydrochloride) tablets now includes clinica...

U.S. FDA Accepts Filing Of NDA for Empagliflozin/Metformin Fixed-Dose Combination

RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-r...

Blacks May Respond Better Than Whites to Diabetes Drug Metformin

THURSDAY, June 12, 2014 -- Blacks with type 2 diabetes may fare better on the widely used drug metformin compared with whites, a new study finds. Researchers analyzed data from more than 19,600 Americ...

Matching PubMed Articles

Anti-Diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy.

Metformin, a biguanide, is a commonly administered drug for the management of type 2 diabetes mellitus. The drug received a lot of recognition, when retrospective studies proved metformin-associated r...

Effect of Metformin on Metabolic Improvement and the Gut Microbiota.

Metformin is commonly used as the first line of medication for treatment of metabolic syndromes such as obesity and type 2 diabetes (T2D). Recently, metformin-induced changes in the gut microbiota hav...

Metformin in Cancer Treatment and Prevention.

Patients with diabetes mellitus are at increased risk of cancer development. Metformin is a well-established, effective agent for the management of type 2 diabetes mellitus. Epidemiological studies ha...

Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy.

Metformin has been a first-line treatment for type II diabetes mellitus for decades and is the most widely prescribed antidiabetic drug. Retrospective studies have found that metformin treatment is as...

The cardiovascular effects of metformin: lost in translation?

In overweight patients with diabetes, treatment with metformin improves cardiovascular outcomes. This observation has fuelled the hypothesis that metformin has direct cardiovascular protective propert...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement